Steroid use in sepsis-induced conjugated hyperbilirubinemia: report of one case

Jinn-Li Wang1, Tsong-Yih Ou, Chun-Nan Chen

  • 1Department of Pediatrics, Taipei Medical University-Wan Fang Medical Center, Taiwan. jlwang@wanfang.gov.tw

Acta Paediatrica Taiwanica = Taiwan Er Ke Yi Xue Hui Za Zhi
|October 5, 2007
PubMed

Insights

Steroids may treat severe conjugated hyperbilirubinemia in children with gram-negative sepsis. This approach rapidly improved a leukemia patient with Escherichia coli sepsis and jaundice.

Area of Science:

  • Pediatric Hematology Oncology
  • Neonatal and Pediatric Sepsis Management
  • Hepatology and Liver Disease

Background:

  • Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
  • Gram-negative bacterial sepsis can lead to severe complications, including liver dysfunction.
  • Conjugated hyperbilirubinemia is a serious condition characterized by elevated direct bilirubin levels.

Observation:

  • A pediatric patient with ALL developed severe conjugated hyperbilirubinemia following Escherichia coli sepsis.
  • The patient's jaundice worsened despite broad-spectrum antibiotic treatment.
  • Neurological status declined, prompting the initiation of steroid therapy.

Findings:

  • Hydrocortisone therapy at 8 mg/kg/d was administered to the patient.
  • Rapid clinical improvement and resolution of hyperbilirubinemia were observed after steroid administration.
  • This suggests a potential therapeutic role for steroids in managing this specific complication.

Implications:

  • Steroid therapy may be a viable treatment option for progressive conjugated hyperbilirubinemia secondary to gram-negative sepsis in pediatric patients.
  • Further research is warranted to confirm the efficacy and safety of steroids in this context.
  • This finding could inform clinical guidelines for managing complex cases of sepsis-induced liver injury in children.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...